JP Morgan Chase’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $185K | Buy |
5,076
+403
| +9% | +$12.8K | ﹤0.01% | 5510 |
|
|
2025
Q4 | $102K | Sell |
4,673
-320
| -6% | -$6.64K | ﹤0.01% | 5881 |
|
|
2025
Q3 | $107K | Sell |
4,993
-7,550
| -60% | -$169K | ﹤0.01% | 5865 |
|
|
2025
Q2 | $322K | Sell |
12,543
-24,462
| -66% | -$716K | ﹤0.01% | 5000 |
|
|
2025
Q1 | $1.35M | Sell |
37,005
-27,687
| -43% | -$952K | ﹤0.01% | 4143 |
|
|
2024
Q4 | $1.98M | Buy |
64,692
+30,860
| +91% | +$1.03M | ﹤0.01% | 4171 |
|
|
2024
Q3 | $1.27M | Buy |
33,832
+22,092
| +188% | +$852K | ﹤0.01% | 4320 |
|
|
2024
Q2 | $465K | Buy |
11,740
+6,043
| +106% | +$196K | ﹤0.01% | 4732 |
|
|
2024
Q1 | $191K | Sell |
5,697
-2,858
| -33% | -$96.1K | ﹤0.01% | 5379 |
|
|
2023
Q4 | $285K | Sell |
8,555
-292
| -3% | -$9.42K | ﹤0.01% | 5138 |
|
|
2023
Q3 | $278K | Sell |
8,847
-7,602
| -46% | -$239K | ﹤0.01% | 4847 |
|
|
2023
Q2 | $521K | Buy |
16,449
+340
| +2% | +$11K | ﹤0.01% | 4467 |
|
|
2023
Q1 | $532K | Buy |
16,109
+1,000
| +7% | +$32.8K | ﹤0.01% | 4460 |
|
|
2022
Q4 | $486K | Buy |
15,109
+1,434
| +10% | +$48.8K | ﹤0.01% | 4543 |
|
|
2022
Q3 | $488K | Buy |
13,675
+3,062
| +29% | +$127K | ﹤0.01% | 4489 |
|
|
2022
Q2 | $436K | Buy |
10,613
+1,497
| +16% | +$72.7K | ﹤0.01% | 4650 |
|
|
2022
Q1 | $527K | Sell |
9,116
-3,080
| -25% | -$168K | ﹤0.01% | 4668 |
|
|
2021
Q4 | $716K | Buy |
12,196
+7,323
| +150% | +$445K | ﹤0.01% | 4609 |
|
|
2021
Q3 | $296K | Sell |
4,873
-724
| -13% | -$42.5K | ﹤0.01% | 5026 |
|
|
2021
Q2 | $335K | Buy |
5,597
+115
| +2% | +$5.76K | ﹤0.01% | 4948 |
|
|
2021
Q1 | $259K | Sell |
5,482
-653
| -11% | -$26.9K | ﹤0.01% | 5041 |
|
|
2020
Q4 | $231K | Sell |
6,135
-468
| -7% | -$15.4K | ﹤0.01% | 4763 |
|
|
2020
Q3 | $221K | Sell |
6,603
-217
| -3% | -$9.19K | ﹤0.01% | 4312 |
|
|
2020
Q2 | $309K | Buy |
6,820
+3,292
| +93% | +$168K | ﹤0.01% | 4071 |
|
|
2020
Q1 | $161K | Sell |
3,528
-688
| -16% | -$31.1K | ﹤0.01% | 4353 |
|
|
2019
Q4 | $182K | Sell |
4,216
-16,470
| -80% | -$671K | ﹤0.01% | 4708 |
|
|
2019
Q3 | $749K | Buy |
20,686
+18,145
| +714% | +$765K | ﹤0.01% | 3994 |
|
|
2019
Q2 | $119K | Sell |
2,541
-3,654
| -59% | -$154K | ﹤0.01% | 4866 |
|
|
2019
Q1 | $218K | Buy |
6,195
+3,803
| +159% | +$149K | ﹤0.01% | 4599 |
|
|
2018
Q4 | $89K | Buy |
2,392
+224
| +10% | +$8.75K | ﹤0.01% | 4886 |
|
|
2018
Q3 | $73K | Sell |
2,168
-279
| -11% | -$8.16K | ﹤0.01% | 5063 |
|
|
2018
Q2 | $61K | Buy |
2,447
+543
| +29% | +$15.1K | ﹤0.01% | 5002 |
|
|
2018
Q1 | $57K | Sell |
1,904
-135
| -7% | -$4.52K | ﹤0.01% | 4776 |
|
|
2017
Q4 | $65K | Buy |
+2,039
| New | +$65.6K | ﹤0.01% | 4808 |
|
|
2017
Q1 | – | Sell |
-2,854
| Closed | -$64K | – | 5033 |
|
|
2016
Q4 | $64K | Buy |
+2,854
| New | +$68.9K | ﹤0.01% | 4498 |
|
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
JP Morgan Chase's ATEX Position: Q1 2026 in Review
JP Morgan Chase increased its Anterix (ATEX) stake by 8.6% in Q1 2026, buying an estimated $12.8K and bringing the position to 5,076 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #5510.
JP Morgan Chase first reported a position in ATEX in Q4 2016 and has held it in 35 quarters since. The position peaked at $1.98M in Q4 2024. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- JP Morgan Chase held 5,076 shares of Anterix worth $185K as of Q1 2026.
- JP Morgan Chase bought 403 Anterix shares in Q1 2026, an estimated $12.8K.
- Anterix made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5510 holding.
- JP Morgan Chase first reported a position in Anterix in Q4 2016 and has held it in 35 quarters since.
- JP Morgan Chase's Anterix position peaked at $1.98M in Q4 2024.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.